Alto Neuroscience, Inc.
Extracted from this filing and checked against the source text.
Alto Neuroscience, Inc.: Adopted amended and restated bylaws in connection with the closing of the IPO (effective 2024-02-06).
Effective as of February 6, 2024, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO. The Board and stockholders previously approved the Restated Bylaws to be effective immediately prior to the closing of the IPO.View on SEC.gov
Alto Neuroscience, Inc.: Amended and restated certificate of incorporation in connection with the closing of the IPO (effective 2024-02-06).
the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware. The Company’s board of directors (the “Board”) and stockholders previously approved the Restated Certificate to be effective as of immediately prior to the closing of the IPO.View on SEC.gov
89 governance changes filed in the last 30 days. Browse all governance changes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.